252 results
Page 9 of 13
6-K
rr7hw4
19 Oct 10
Early Initiation of Treatment with Copaxone? Provides Greater Effects In Delaying Conversion to Clinically Definite MS
12:00am
6-K
el8js9hn7ttx1
19 Oct 10
Early Initiation of Treatment with Copaxone? Provides Greater Effects In Delaying Conversion to Clinically Definite MS
12:00am
6-K
i6o7vfi7
18 Oct 10
New Data Evaluating Laquinimod for the Treatment of Multiple Sclerosis Demonstrate Neuroprotective Effects
12:00am
6-K
j9yjejc rv21y993b
21 Sep 10
Oral Laquinimod Demonstrated Sustained Efficacy and Safety In Patients with Multiple Sclerosis
12:00am
6-K
pra7sat82jzr1 oj
27 Jul 10
Current report (foreign)
12:00am
S-8
EX-99.1
t6aknjdvedq8
27 Jul 10
Registration of securities for employees
12:00am
6-K
yu4szri
27 Jul 10
Current report (foreign)
12:00am
6-K
EX-1.1
aw98 npqdo8qa0j9bp9
18 Jun 10
Current report (foreign)
12:00am
6-K
EX-1.2
hhccez9 0y91
18 Jun 10
Current report (foreign)
12:00am
6-K
EX-4.2
2q4gh2 4rc
18 Jun 10
Current report (foreign)
12:00am
6-K
EX-4.4
9z5 9shv0q8pr703xp
18 Jun 10
Current report (foreign)
12:00am
6-K
tlsj6s7tk009x7 4qg
17 Jun 10
Teva Announces Pricing of $2.5 Billion of Senior Notes
12:00am
6-K
kqake1wq
18 May 10
Current report (foreign)
12:00am
6-K
7nwj1
4 May 10
Current report (foreign)
12:00am
6-K
qn17c0801tgnp3brm
4 May 10
Current report (foreign)
12:00am
6-K
ltount8ygojvr544
16 Apr 10
New Data Suggest Oral Laquinimod May Confer Neuroprotection In Addition to Immunomodulation In the Treatment of Multiple Sclerosis
12:00am
6-K
y4c3nqrbysljyh3s90
3 Nov 09
Current report (foreign)
12:00am
6-K
njqpbezmqeml 9zs0gd
3 Nov 09
Current report (foreign)
12:00am